» Articles » PMID: 30206268

Nystatin-like Pseudonocardia Polyene B1, a Novel Disaccharide-containing Antifungal Heptaene Antibiotic

Overview
Journal Sci Rep
Specialty Science
Date 2018 Sep 13
PMID 30206268
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Polyene macrolides such as nystatin A1 and amphotericin B belong to a large family of very valuable antifungal polyketide compounds typically produced by soil actinomycetes. Recently, nystatin-like Pseudonocardia polyene (NPP) A1 has been identified as a unique disaccharide-containing tetraene antifungal macrolide produced by Pseudonocardia autotrophica. Despite its significantly increased water solubility and decreased hemolytic activity, its antifungal activity remains limited compared with that of nystatin A1. In this study, we developed NPP B1, a novel NPP A1 derivative harboring a heptaene core structure, by introducing two amino acid substitutions in the putative NADPH-binding motif of the enoyl reductase domain in module 5 of the NPP A1 polyketide synthase NppC. The low level NPP B1 production yield was successfully improved by eliminating the native plasmid encoding a polyketide biosynthetic gene cluster present in P. autotrophica. In vitro and in vivo antifungal activity and toxicity studies indicated that NPP B1 exhibited comparable antifungal activity against Candida albicans and was less toxic than the most potent heptaene antifungal, amphotericin B. Moreover, NPP B1 showed improved pharmacokinetic parameters compared to those of amphotericin B, suggesting that NPP B1 could be a promising candidate for development into a pharmacokinetically improved and less-toxic polyene antifungal antibiotic.

Citing Articles

Polyene-Based Derivatives with Antifungal Activities.

Ngece K, Ntondini T, Khwaza V, Paca A, Aderibigbe B Pharmaceutics. 2024; 16(8).

PMID: 39204411 PMC: 11360744. DOI: 10.3390/pharmaceutics16081065.


Bioactive Metabolites from Terrestrial and Marine Actinomycetes.

Ngamcharungchit C, Chaimusik N, Panbangred W, Euanorasetr J, Intra B Molecules. 2023; 28(15).

PMID: 37570885 PMC: 10421486. DOI: 10.3390/molecules28155915.


Effect of PAS-LuxR Family Regulators on the Secondary Metabolism of .

Zhang N, Dong Y, Zhou H, Cui H Antibiotics (Basel). 2022; 11(12).

PMID: 36551440 PMC: 9774167. DOI: 10.3390/antibiotics11121783.


Antifungal metabolites, their novel sources, and targets to combat drug resistance.

Choudhary M, Kumar V, Naik B, Verma A, Saris P, Kumar V Front Microbiol. 2022; 13:1061603.

PMID: 36532457 PMC: 9755354. DOI: 10.3389/fmicb.2022.1061603.


BAC Cloning of a Large-Sized Biosynthetic Gene Cluster of NPP B1, a Potential SARS-CoV-2 RdRp Inhibitor.

Park J, Park H, Nah H, Kang S, Choi S, Kim E J Microbiol Biotechnol. 2022; 32(7):911-917.

PMID: 35719079 PMC: 9628923. DOI: 10.4014/jmb.2205.05036.


References
1.
Kim H, Kim M, Lee M, Won H, Choi S, Kim E . Post-PKS tailoring steps of a disaccharide-containing polyene NPP in Pseudonocardia autotrophica. PLoS One. 2015; 10(4):e0123270. PMC: 4388683. DOI: 10.1371/journal.pone.0123270. View

2.
Davis S, Vincent B, Endo M, Whitesell L, Marchillo K, Andes D . Nontoxic antimicrobials that evade drug resistance. Nat Chem Biol. 2015; 11(7):481-7. PMC: 4472574. DOI: 10.1038/nchembio.1821. View

3.
Sweeney P, Murphy C, Caffrey P . Exploiting the genome sequence of Streptomyces nodosus for enhanced antibiotic production. Appl Microbiol Biotechnol. 2015; 100(3):1285-1295. DOI: 10.1007/s00253-015-7060-9. View

4.
Kim H, Kang S, Choi S, Kim E . Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. Appl Microbiol Biotechnol. 2017; 101(12):5131-5137. DOI: 10.1007/s00253-017-8303-8. View

5.
Onishi M, Kamimori H . High-throughput and sensitive assay for amphotericin B interaction with lipid membrane on the model membrane systems by surface plasmon resonance. Biol Pharm Bull. 2013; 36(4):658-63. DOI: 10.1248/bpb.b12-01020. View